Companion Animals

Canine Immune-Mediated Polyarthritis: Welfare and Management

Immune-mediated polyarthritis is a painful inflammatory joint condition in dogs that requires long-term immunosuppressive treatment and careful welfare monitoring.

Key Facts

Immune-mediated polyarthritis affects multiple joints simultaneously in affected dogs
Clinical signs include fever, lethargy, reluctance to move, and joint swelling
Diagnosis requires joint fluid analysis and ruling out infectious causes
Long-term immunosuppressive therapy is often required to manage the condition
Relapses are common and require ongoing veterinary monitoring

Welfare Considerations

Dogs with immune-mediated polyarthritis experience significant pain and restricted mobility during flares. The chronic nature of the condition and dependence on immunosuppressive drugs create ongoing welfare challenges including infection risk, gastrointestinal side effects, and reduced quality of life. Pain assessment using validated scales, careful drug tapering, and physiotherapy support are key components of welfare-centred management for affected dogs.

What You Can Do

Seek prompt veterinary diagnosis if your dog shows signs of joint pain and fever
Follow prescribed immunosuppressive protocols and attend all follow-up appointments
Use validated pain assessment tools to monitor welfare during treatment
Incorporate gentle hydrotherapy or physiotherapy to maintain joint mobility
Keep detailed symptom diaries to help identify relapse triggers early